Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M
Allozymes uses a method in which millions of enzymes can be tested per day, rather than just a few hundred.
Stay updated with breaking news from Thia Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allozymes uses a method in which millions of enzymes can be tested per day, rather than just a few hundred.
Allozymes' ingenious method of quickly testing millions of bio-based chemical reactions is proving to be not just a useful service, but the basis of a unique and valuable dataset. The company just raised a $15 million Series A to grow its business from a helpful service to a world-class resource. The company has grown to 32 people in the U.S., Europe and Singapore, and has 15 times the lab space, which it has used to accelerate its already exponentially faster enzyme-screening technique.
Biotech startup, Clever Carnivore, closed $7m of seed round funding to expand production of its low-cost cultivated pork sausage with plans to launch its prototype, the Clever Bratwurst in early 2024 without asking the consumer to pay more, Virginia Rangos, the company’s CEO and co-founder told FoodNavigator-USA.
The cultivated meat company plans to increase expansion plans.
Clever Carnivore, a US-based cultivated-meat business, has raised $7m in a funding round from a group of investors.